302 related articles for article (PubMed ID: 15527675)
1. Zollinger-Ellison syndrome revisited: diagnosis, biologic markers, associated inherited disorders, and acid hypersecretion.
Gibril F; Jensen RT
Curr Gastroenterol Rep; 2004 Dec; 6(6):454-63. PubMed ID: 15527675
[TBL] [Abstract][Full Text] [Related]
2. All you need to know about gastrinoma today | Gastrinoma and Zollinger-Ellison syndrome: A thorough update.
Chatzipanagiotou O; Schizas D; Vailas M; Tsoli M; Sakarellos P; Sotiropoulou M; Papalambros A; Felekouras E
J Neuroendocrinol; 2023 Apr; 35(4):e13267. PubMed ID: 37042078
[TBL] [Abstract][Full Text] [Related]
3. Gastrinoma and Zollinger Ellison syndrome: A roadmap for the management between new and old therapies.
Rossi RE; Elvevi A; Citterio D; Coppa J; Invernizzi P; Mazzaferro V; Massironi S
World J Gastroenterol; 2021 Sep; 27(35):5890-5907. PubMed ID: 34629807
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of the standard meal provocative test in Zollinger-Ellison syndrome.
Frucht H; Howard JM; Stark HA; McCarthy DM; Maton PN; Gardner JD; Jensen RT
Am J Med; 1989 Nov; 87(5):528-36. PubMed ID: 2573280
[TBL] [Abstract][Full Text] [Related]
5. Prospective study of the value of serum chromogranin A or serum gastrin levels in the assessment of the presence, extent, or growth of gastrinomas.
Goebel SU; Serrano J; Yu F; Gibril F; Venzon DJ; Jensen RT
Cancer; 1999 Apr; 85(7):1470-83. PubMed ID: 10193936
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis and treatment of gastrinoma in the era of proton pump inhibitors.
Banasch M; Schmitz F
Wien Klin Wochenschr; 2007; 119(19-20):573-8. PubMed ID: 17985090
[TBL] [Abstract][Full Text] [Related]
7. Serum gastrin in Zollinger-Ellison syndrome: I. Prospective study of fasting serum gastrin in 309 patients from the National Institutes of Health and comparison with 2229 cases from the literature.
Berna MJ; Hoffmann KM; Serrano J; Gibril F; Jensen RT
Medicine (Baltimore); 2006 Nov; 85(6):295-330. PubMed ID: 17108778
[TBL] [Abstract][Full Text] [Related]
8. [Diagnostic and therapeutic strategies in Zollinger-Ellison syndrome associated with multiple endocrine neoplasia type I (MEN-I): experience of the Zollinger-Ellison Syndrome Research Group: Bichat 1958-1999].
Mignon M
Bull Acad Natl Med; 2003; 187(7):1249-58; discussion 1259-60. PubMed ID: 15146602
[TBL] [Abstract][Full Text] [Related]
9. Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature.
Gibril F; Schumann M; Pace A; Jensen RT
Medicine (Baltimore); 2004 Jan; 83(1):43-83. PubMed ID: 14747767
[TBL] [Abstract][Full Text] [Related]
10. Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome-over a decade of follow-up.
Daniels LM; Khalili M; Morano WF; Simoncini M; Mapow BC; Leaf A; Bowne WB
World J Surg Oncol; 2019 Dec; 17(1):213. PubMed ID: 31818296
[TBL] [Abstract][Full Text] [Related]
11. A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.
Berna MJ; Annibale B; Marignani M; Luong TV; Corleto V; Pace A; Ito T; Liewehr D; Venzon DJ; Delle Fave G; Bordi C; Jensen RT
J Clin Endocrinol Metab; 2008 May; 93(5):1582-91. PubMed ID: 18270260
[TBL] [Abstract][Full Text] [Related]
12. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.
Richards ML; Gauger P; Thompson NW; Giordano TJ
World J Surg; 2004 Jul; 28(7):652-8. PubMed ID: 15383867
[TBL] [Abstract][Full Text] [Related]
13. Assessing for Multiple Endocrine Neoplasia Type 1 in Patients Evaluated for Zollinger-Ellison Syndrome-Clues to a Safer Diagnostic Process.
Singh Ospina N; Donegan D; Rodriguez-Gutierrez R; Al-Hilli Z; Young WF
Am J Med; 2017 May; 130(5):603-605. PubMed ID: 28011308
[TBL] [Abstract][Full Text] [Related]
14. Gastric enterochromaffin-like cell changes in multiple endocrine neoplasia type 1.
Manoharan J; Anlauf M; Albers MB; Denzer UW; Mintziras I; Wächter S; Di Fazio P; Bollmann C; Bartsch DK
Clin Endocrinol (Oxf); 2021 Sep; 95(3):439-446. PubMed ID: 33506527
[TBL] [Abstract][Full Text] [Related]
15. Zollinger-Ellison syndrome: recent advances and controversies.
Ito T; Igarashi H; Jensen RT
Curr Opin Gastroenterol; 2013 Nov; 29(6):650-61. PubMed ID: 24100728
[TBL] [Abstract][Full Text] [Related]
16. Zollinger-Ellison syndrome. Clinical presentation in 261 patients.
Roy PK; Venzon DJ; Shojamanesh H; Abou-Saif A; Peghini P; Doppman JL; Gibril F; Jensen RT
Medicine (Baltimore); 2000 Nov; 79(6):379-411. PubMed ID: 11144036
[TBL] [Abstract][Full Text] [Related]
17. Zollinger-Ellison syndrome. Diagnosis and therapy.
Campana D; Piscitelli L; Mazzotta E; Bonora M; Serra C; Salomone L; Corinaldesi R; Tomassetti P
Minerva Med; 2005 Jun; 96(3):187-206. PubMed ID: 16175161
[TBL] [Abstract][Full Text] [Related]
18. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.
Anlauf M; Garbrecht N; Henopp T; Schmitt A; Schlenger R; Raffel A; Krausch M; Gimm O; Eisenberger CF; Knoefel WT; Dralle H; Komminoth P; Heitz PU; Perren A; Klöppel G
World J Gastroenterol; 2006 Sep; 12(34):5440-6. PubMed ID: 17006979
[TBL] [Abstract][Full Text] [Related]
19. Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients.
Tomassetti P; Salomone T; Migliori M; Campana D; Corinaldesi R
Drugs Aging; 2003; 20(14):1019-34. PubMed ID: 14651442
[TBL] [Abstract][Full Text] [Related]
20. The effect of Zollinger-Ellison syndrome and neuropeptide-secreting tumors on the stomach.
Pisegna JR
Curr Gastroenterol Rep; 1999 Dec; 1(6):511-7. PubMed ID: 10980995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]